Inspection Record

Medisca Pharmaceutique Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-01-30 5 findingsStability and storageMaterial and supplier controlComplaint and recall handlingDeviation, CAPA, and investigationOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

The company did not assess the results and/or take corrective actions for stability testing results that were out-of-specification, borderline, or out-of-trend .

2Material and supplier control

The handling of raw materials, products, or packaging materials in keeping with pre-approved written procedures or instructions was inadequate.

3Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

4Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

5Other quality system

The assessment to release finished products was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-01-30. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Medisca Pharmaceutique Inc. company profile — full history Health Canada documents, 2024 Go to Findings search